These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4446097)

  • 1. [Incidence of thrombosis and the status of coagulation in ischaemic heart disease].
    Gormsen J; Andersen LA
    Ugeskr Laeger; 1974 Dec; 136(49):2727-35. PubMed ID: 4446097
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of some drugs on platelet aggregation: a study in hypertensive patients.
    Bologna E
    Acta Univ Carol Med Monogr; 1972; 52():87-92. PubMed ID: 4669830
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of anturan in patients with ischemic heart disease with a history of acute myocardial infarction].
    Bokarev IN; Golikov AP; Liusov VA; Ptushkin VV; Zvereva TV
    Klin Med (Mosk); 1987 Oct; 65(10):29-32. PubMed ID: 3431051
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of aspirin in ischemic heart disease].
    Frishman W; Horwitz S
    Arch Inst Cardiol Mex; 1977; 47(2):129-31. PubMed ID: 901049
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects of control in therapy with platelet inhibitors].
    Bokarev IN; Ovcinnikova LV; Aleksandrova NA; Kabaeva EV; Marcukova EV; Kun IS; Olbinskaja LI
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):776-82. PubMed ID: 94869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spontaneous thrombocyte aggregation in patients with ischemic cardiopathy. Effect of anti-aggregant treatment on thrombocyte function and other coagulation factors].
    Niţă I; Papilian M; Theodorini S; Stroescu V
    Med Interne; 1984; 22(2):113-22. PubMed ID: 6740182
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current clinical results of antiplatelet medication].
    Ordinas A
    Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
    [No Abstract]   [Full Text] [Related]  

  • 14. [Platelet antiaggregants and arteriopathies].
    Cristol R
    J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombosis prevention by coagulation and platelet aggregtion inhibitors, in hyperlipemic rats.
    Renaud S; Lecompte F
    Thromb Diath Haemorrh; 1970 Dec; 24(3):577-86. PubMed ID: 5503948
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary study of effect of aspirin and dipyridamole on platelet adhesiveness and fibrinolytic activity in acute myocardial infarction.
    Jhawar BK; Trivedi HH; Bhargava RK; Misra NP
    J Assoc Physicians India; 1978 Sep; 26(9):805-9. PubMed ID: 370078
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 19. [Checking of various hemostatic indices in patients with vascular diseases before and after treatment with inhibitors of platelet adhesiveness].
    Patrone F; Armani U; Boy E; Botta G; Boccaccio P
    Minerva Cardioangiol; 1975; 23(6-7):379-91. PubMed ID: 1143662
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of platelet aggregation by drugs.
    Glusa E
    Acta Univ Carol Med Monogr; 1972; 52():83-6. PubMed ID: 4669829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.